This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Eu Sol Biotech Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Ming-Jei Lo
Introduction
Ming-Jei Lo is a prominent inventor based in Taipei, Taiwan. He has made significant strides in the field of neurodegeneration treatment. His work focuses on innovative methods to address nerve compression syndrome and entrapment neuropathy.
Latest Patents
Ming-Jei Lo holds a patent for a method aimed at repairing neurodegeneration. The patent, titled "Method for repairing neurodegeneration," provides a novel approach that involves administering human acidic fibroblast growth factor (aFGF), fibrinogen, aprotinin, and divalent calcium ions to individuals in need. This innovative treatment has the potential to improve the quality of life for those suffering from nerve-related conditions.
Career Highlights
Ming-Jei Lo is associated with Eu Sol Biotech Co., Ltd., where he continues to develop and refine his groundbreaking ideas. His dedication to research and innovation has positioned him as a key figure in the biotechnology sector.
Collaborations
Ming-Jei Lo collaborates with notable colleagues, including Henrich Cheng and Yee-Chiang Liu. Their combined expertise fosters a dynamic environment for advancing research and development in their field.
Conclusion
Ming-Jei Lo's contributions to the field of neurodegeneration treatment exemplify the impact of innovative thinking in biotechnology. His work not only addresses critical health issues but also paves the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile